228 related articles for article (PubMed ID: 31571092)
21. Clinical Value of Serum Neuron-Specific Enolase Combined with Serum S100B Protein in the Diagnosis of Systemic Lupus Erythematosus.
Chen J; Yan Cheng ; Zhang X; Wang F; Chuai X
Contrast Media Mol Imaging; 2022; 2022():9390991. PubMed ID: 35615727
[TBL] [Abstract][Full Text] [Related]
22. Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy.
Itakura H; Kishi S; Kotajima N; Murakami M
Ophthalmology; 2004 Oct; 111(10):1880-4. PubMed ID: 15465550
[TBL] [Abstract][Full Text] [Related]
23. Serum Levels of S100b and NSE Proteins in Patients with Non-Transfusion-Dependent Thalassemia as Biomarkers of Brain Ischemia and Cerebral Vasculopathy.
Kanavaki A; Spengos K; Moraki M; Delaporta P; Kariyannis C; Papassotiriou I; Kattamis A
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29244749
[TBL] [Abstract][Full Text] [Related]
24. Prognostic Value of Serum Levels of S100 Calcium-Binding Protein B, Neuron-Specific Enolase, and Interleukin-6 in Pediatric Patients with Traumatic Brain Injury.
Park SH; Hwang SK
World Neurosurg; 2018 Oct; 118():e534-e542. PubMed ID: 30257306
[TBL] [Abstract][Full Text] [Related]
25. Increased Vitreous Chemerin Levels Are Associated with Proliferative Diabetic Retinopathy.
Li J; Hu WC; Song H; Lin JN; Tang X
Ophthalmologica; 2016; 236(2):61-6. PubMed ID: 27548269
[TBL] [Abstract][Full Text] [Related]
26. Serum Neuronal Biomarkers in Neonates With Congenital Heart Disease Undergoing Cardiac Surgery.
Trakas E; Domnina Y; Panigrahy A; Baust T; Callahan PM; Morell VO; Munoz R; Bell MJ; Sanchez-de-Toledo J
Pediatr Neurol; 2017 Jul; 72():56-61. PubMed ID: 28571730
[TBL] [Abstract][Full Text] [Related]
27. Quantitative analysis of interleukin-6 in vitreous from patients with proliferative vitreoretinal diseases.
Kojima S; Yamada T; Tamai M
Jpn J Ophthalmol; 2001; 45(1):40-5. PubMed ID: 11163044
[TBL] [Abstract][Full Text] [Related]
28. The role of S100B protein, neuron-specific enolase, and glial fibrillary acidic protein in the evaluation of hypoxic brain injury in acute carbon monoxide poisoning.
Akdemir HU; Yardan T; Kati C; Duran L; Alacam H; Yavuz Y; Okuyucu A
Hum Exp Toxicol; 2014 Nov; 33(11):1113-20. PubMed ID: 24505052
[TBL] [Abstract][Full Text] [Related]
29. Utility of neuron-specific enolase in traumatic brain injury; relations to S100B levels, outcome, and extracranial injury severity.
Thelin EP; Jeppsson E; Frostell A; Svensson M; Mondello S; Bellander BM; Nelson DW
Crit Care; 2016 Sep; 20():285. PubMed ID: 27604350
[TBL] [Abstract][Full Text] [Related]
30. A comparison of sex steroid concentration levels in the vitreous and serum of patients with vitreoretinal diseases.
Nishikawa Y; Morishita S; Horie T; Fukumoto M; Sato T; Kida T; Oku H; Sugasawa J; Ikeda T; Nakamura K
PLoS One; 2017; 12(7):e0180933. PubMed ID: 28704441
[TBL] [Abstract][Full Text] [Related]
31. Endodiathermy plus photocoagulation as treatment of sclerotomy site vascularization secondary to pars plana vitrectomy for proliferative diabetic retinopathy.
Nadal J; Carreras E; Canut MI
Retina; 2012 Jul; 32(7):1310-5. PubMed ID: 22466471
[TBL] [Abstract][Full Text] [Related]
32. Serial measurement of S100B and NSE in pediatric traumatic brain injury.
Park DW; Park SH; Hwang SK
Childs Nerv Syst; 2019 Feb; 35(2):343-348. PubMed ID: 30171330
[TBL] [Abstract][Full Text] [Related]
33. Increased vitreous concentrations of MCP-1 and IL-6 after vitrectomy in patients with proliferative diabetic retinopathy: possible association with postoperative macular oedema.
Yoshida S; Kubo Y; Kobayashi Y; Zhou Y; Nakama T; Yamaguchi M; Tachibana T; Ishikawa K; Arita R; Nakao S; Sassa Y; Oshima Y; Kono T; Ishibashi T
Br J Ophthalmol; 2015 Jul; 99(7):960-6. PubMed ID: 25631486
[TBL] [Abstract][Full Text] [Related]
34. Three-Dimensional Enhanced Imaging of Vitreoretinal Interface in Diabetic Retinopathy Using Swept-Source Optical Coherence Tomography.
Adhi M; Badaro E; Liu JJ; Kraus MF; Baumal CR; Witkin AJ; Hornegger J; Fujimoto JG; Duker JS; Waheed NK
Am J Ophthalmol; 2016 Feb; 162():140-149.e1. PubMed ID: 26548809
[TBL] [Abstract][Full Text] [Related]
35. PERSISTENT OVERPRODUCTION OF INTRAOCULAR VASCULAR ENDOTHELIAL GROWTH FACTOR AS A CAUSE OF LATE VITREOUS HEMORRHAGE AFTER VITRECTOMY FOR PROLIFERATIVE DIABETIC RETINOPATHY.
Wakabayashi Y; Usui Y; Tsubota K; Ueda S; Umazume K; Muramatsu D; Goto H
Retina; 2017 Dec; 37(12):2317-2325. PubMed ID: 28098727
[TBL] [Abstract][Full Text] [Related]
36. Association of vitreous vitamin C depletion with diabetic macular ischemia in proliferative diabetic retinopathy.
Park SW; Ghim W; Oh S; Kim Y; Park UC; Kang J; Yu HG
PLoS One; 2019; 14(6):e0218433. PubMed ID: 31216331
[TBL] [Abstract][Full Text] [Related]
37. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
Watanabe D; Suzuma K; Suzuma I; Ohashi H; Ojima T; Kurimoto M; Murakami T; Kimura T; Takagi H
Am J Ophthalmol; 2005 Mar; 139(3):476-81. PubMed ID: 15767056
[TBL] [Abstract][Full Text] [Related]
38. Influence of Blood-Brain Barrier Integrity on Brain Protein Biomarker Clearance in Severe Traumatic Brain Injury: A Longitudinal Prospective Study.
Lindblad C; Nelson DW; Zeiler FA; Ercole A; Ghatan PH; von Horn H; Risling M; Svensson M; Agoston DV; Bellander BM; Thelin EP
J Neurotrauma; 2020 Jun; 37(12):1381-1391. PubMed ID: 32013731
[TBL] [Abstract][Full Text] [Related]
39. The impact of ranibizumab on the level of intercellular adhesion molecule type 1 in the vitreous of eyes with proliferative diabetic retinopathy.
Yan Y; Zhu L; Hong L; Deng J; Song Y; Chen X
Acta Ophthalmol; 2016 Jun; 94(4):358-64. PubMed ID: 26285163
[TBL] [Abstract][Full Text] [Related]
40. Human vitreal prostaglandin levels and proliferative diabetic retinopathy.
Douros S; Phillips BA; Nadel A; Obstbaum SA
Doc Ophthalmol; 2001 Jul; 103(1):27-34. PubMed ID: 11678158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
